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of fully assessing public safety risk in advance of use. 
Indeed, such assessment can only be undertaken dy-
namically, by evaluating the risk (and benefit) of the 
‘thing in use’ as the creation of ongoing “interactions 
between hazards, people with all their behaviours 
and the ever-changing environment”6. 
The book gives clear insight into the latent pro-
cesses of decision making and the assumptions and 
philosophies that lie un-explored beneath the surface 
of contemporary ways of thinking and talking about 
risk and safety. The authors call for greater attention 
to narrative-based assessment of risk, and a move 
away from abstract schematic checklists and matri-
ces. They consider (and draw upon recent develop-
ments in the psychology of decision making to sup-
port their argument) that safety can only be evaluated 
as part of sense-making of the entirety of a proposal 
or project. Safety and risk must be blended into the 
story – there must be clear policy goals against which 
to evaluate the safety risks and other (perhaps even 
more significant) benefits that accepting those risks 
will accrue. Here the authors invoke Margolis’ con-
ceptualisation of the ‘fungibility’ of risks7 – that the 
public and managers of public safety must live and 
breathe the evaluation of trade-offs that the quest for 
ever greater levels of safety may entail. 
The current UK coalition Government (like the 
socialist Labour Government that preceded it) sees 
a move away from ‘excessive’ safety regulation as 
a necessary step in formation of a risk-embracing 
and entrepreneurial national mind-set8. Time will 
tell whether the ‘Health & Safety Culture’ which 
the authors’ oppose, can be countered through de-
regulation and reform of regulatory guidance. As 
the authors acknowledge, the use and management 
of public spaces, and the tacit knowledge informing 
those practices is both complex and dynamic9. 
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This book is a welcome addition to the political sci-
ence literature on medical product policymaking. 
Most researchers see medical devices as a poorer and 
perhaps less glamourized neighbour of the pharma-
ceutical regulation. Of course, pharmaceutical regu-
lation has been besieged with academic debates on 
public health concerns and access. Similar lines of 
arguments also persist in the medical devices, but 
one aspect remains unique, that of the design of the 
regulatory regime itself – which is a sui generis to 
Europe (and therefore a truly european experiment) 
characterised by public roles played by private actors 
within a distinctly federal structure (allows for a well 
formulated role of member states). Therein lies the 
reason why the book brings in a distinct and largely 
missing voice in the academic literature on medical 
products. The book primarily looks at the evolving 
institutional scene of French medical device regula-
tion and links this up with the regulatory develop-
ments in Europe. The choice of frame here is very 
important. Professor Altenstetter chooses to focus 
on France. The adoption of a state lens allows her to 
focus on regulatory cultures, major national events 
and domestic institutional dynamics in the ways in 
which they converge or diverge at certain points in 
history to influence the European policymaking. The 
other part is to see how European policy decisions 
are in a certain way indigenised (for lack of a bet-
ter word) when implemented in member states. One 
does always suspect that this would happen, but this 
book provides a rich a detailed analysis in terms of 
motivations of individual actors and brilliantly dis-
plays the complexity of both arriving at and then 
implementing those policy outcomes. Further, its 
choice of adopting a national lens, allows it to pro-
vide an overview of developments in all the device 
sectors (general medical devices, in vitro diagnostics 
and also active implantable devices), and also focus 
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attention on one of the principal actors (the others 
being UK and Germany) in negotiating a European 
regulatory regime. 
The book includes thirteen chapters. The first 
three chapters provides a detailed background of 
the industry profile of medical devices in Europe, 
in terms of the players, products and geographi-
cal distribution of products across the three main 
markets – Germany, U.K. and France. The European 
policy context is also delved into this section. The 
focus of these sections is three fold. First, it discuss-
es the unique characteristics of medical devices as 
an industry and discusses the European policy im-
peratives that have influenced its unique regulatory 
architecture. Second, connection is made between 
the industrial developments and the realignment 
of state-business relationships within the French 
government. Third, the HIV-contaminated blood 
scandal is discussed as a policy spur that had a long 
lasting impact on French attitudes, negotiating posi-
tions and ultimately influences on European policy. 
Chapters 4 to 6 primarily discuss the impact of the 
health crisis in France. The focus is on understand-
ing the concept of securité sanitaire that forms the 
bedrock of the French health policy and how has 
it evolved eventually clashing with the European 
regulatory philosophy of the single market that was 
driving the medical device regulations. Other result-
ing influences of the health crisis – referred to as 
“judicialization” – simply put the culture of litigation 
has been growing in France and this also may have 
an impact on health policymaking in terms of tak-
ing a more risk-averse stance. Chapter 8 discusses 
the European negotiations on the IVDD and the 
successful push by the French delegation to include 
vigilance as a mandatory requirement for all medi-
cal devices. However by no means, this was a pan 
French policy position – it was a result of a hard 
fought battle, won by the ministry of health on one 
side and the ministries of finance and  industry on 
the other. Thus reflecting the inter agency conflicts 
and the public pressure that propelled the former to 
win a rare victory. 
The subsequent chapters (chapters 9 and 10) fo-
cuses attention on the setting up and operations of 
the French health agency AFSSAPS that has polic-
ing powers over all healthcare and medical products. 
Chapter 11 and 12 explores the local dimension of 
the implementation of vigilance systems by a num-
ber of administrative and professional stakeholders. 
It highlights the intricate (and sometimes discon-
nected) network of doctors, hospital administrators, 
clinicians, local vigilance officials that have to opera-
tionalize rules that they inherit via a command and 
control structure of the Paris bureaucracy. Despite 
the challenges, the last chapter in fact manages to 
pull together several strands of arguments discussed 
in the earlier chapters. It highlights the impacts of 
modernization and institutional engineering that 
have characterised the public administration reforms 
agenda in the nineties in France. More importantly, 
the book argues that despite positively steering Eu-
ropean policy towards higher standards of patient 
safety, nationally, France lacks the implementation 
capacity to effectively see through the same reforms 
that it has been advocating at the European level. 
The author adopts an effective tool to discuss the 
overall picture in France, by discussing them in the 
context of eight public health principles drawn up by 
the WHO (World Health Organization). Another im-
portant aspect discussed briefly but illuminatingly in 
the book is the rapid global harmonization of regula-
tory practices through the GHTF (Global Harmoniza-
tion Task Force). 
The book is a result of painstaking research and 
is based on more than eighty expert interviews of 
the principal actors which the author held in the late 
nineties and early 2000. This book is rich in detail 
and allows the reader to get an in-depth look into 
the modern history and development of the regula-
tory apparatus and the actors that are involved in 
medical devices in France. Medical devices regula-
tion is a largely understudied but an exciting area, 
and this book provides an absorbing account of the 
national dynamics and it impact on European regu-
lation. The book also provides a rich material for fu-
ture research on the national imperatives for global 
harmonization, impact and influence of a range of 
local actors on regulatory implementation, the influ-
ence of disciplinary backgrounds in interpreting and 
implementing regulatory rules, etc. The only quibble, 
which I had with the book, was in terms of organi-
zation. Chapters should have been grouped together 
under sub-headings. The book would have benefitted 
immensely from a clearer differentiation of either 
thematic areas or geographical coverage – in terms of 
national and European dynamics. Nevertheless, this 
book would appeal to both generalists and special-
ists alike from political science, law and regulatory 
studies and sociology.
